title: [Effect of aluminum phosphate gel and Kangfuxin on esophageal pathology and IL-8 and PGE2 expressions in a rat model of reflux esophagitis].
abstract: OBJECTIVE
  To explore the effect of aluminum phosphate gel and Kangfuxin on esophageal pathology and expressions of interleukin-8 (IL-8) and prostaglandin E2 (PGE2) in rats with reflux esophagitis and explore the possible mechanisms.
  
  
  METHODS
  Sixty SD rats were randomized into aluminum phosphate gel group (n=10), Kangfuxin group (n=10), aluminum phosphate gel+Kangfuxin group (n=10), model group (n=20), and control group (n=10). Except for those in the control group, all the rats were subjected to infusion of diluted lysolecithin with hydrochloric acid in the esophagus for 14 days. Ten rats in the model group and those in the control group were sacrificed to examine the pathological changes and contents of IL-8 and PGE2 in the esophagus using optical and electron microscopes and radioimmunoassay. The next day the rest rats were given corresponding treatments (saline in model group) administered into the esophagus on a daily basis for 14 days, after which esophageal pathologies and IL-8 and PGE2 contents were examined.
  
  
  RESULTS
  The model rats showed obvious esophageal pathologies including inflammatory cell infiltration, vacuolar degeneration of the epithelial cells, esophageal erosion and even ulceration, with severe detachment of the epithelial cells. The rats in all the intervention groups showed lessened esophageal pathologies and lowered esophageal IL-8 and PGE2 contents compared with those in the model group. Esophageal mucosal injury index and IL-8 and PGE2 contents were all significantly lower in rats receiving combined treatment with aluminum phosphate and Kangfuxin than in those receiving either of the treatments (P<0.05).
  
  
  CONCLUSIONS
  Both Kangfuxin and aluminum phosphate gel are effective in the treatment for reflux esophagitis induced by lysolecithin and hydrochloric acid, and their therapeutic effects are achieved possibly by reducing IL-8 and PGE2 levels in the esophagus.
authors.affiliation: Endoscopic Clinic, Tumor Hospital Affiliated to Guangxi Medical University, Department of Infectious Diseases, Nanning 530000, China. E-mail: beihailhl@126.com.
authors.forename: Hai-Ling
authors.initials: HL
authors.lastname: Lin
authors.forename: Guo-Jian
authors.initials: GJ
authors.lastname: Li
authors.forename: Ji-Zhou
authors.initials: JZ
authors.lastname: Wu
mesh_terms: D017607:Aluminum Compounds / Q000494:pharmacology*; D000818:Animals; D015232:Dinoprostone / Q000378:metabolism*; D004195:Disease Models, Animal; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004942:Esophagitis, Peptic / Q000188:drug therapy / Q000378:metabolism*; D004947:Esophagus / Q000187:drug effects / Q000473:pathology; D005782:Gels; D016209:Interleukin-8 / Q000378:metabolism*; D010710:Phosphates / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D017607:Aluminum Compounds; D004365:Drugs, Chinese Herbal; D005782:Gels; D016209:Interleukin-8; D010710:Phosphates; C012714:aluminum phosphate; D015232:Dinoprostone